瑞芬太尼
异丙酚
外推法
医学
靶控输注
人口
麻醉
计算机科学
重症监护医学
数学
统计
环境卫生
作者
Remco Vellinga,Douglas J. Eleveld,Michel Struys,Johannes P. van den Berg
出处
期刊:Current Opinion in Anesthesiology
[Ovid Technologies (Wolters Kluwer)]
日期:2023-08-08
卷期号:36 (5): 602-607
被引量:1
标识
DOI:10.1097/aco.0000000000001300
摘要
Purpose of review There are various pharmacokinetic-dynamic models available, which describe the time course of drug concentration and effect and which can be incorporated into target-controlled infusion (TCI) systems. For anesthesia and sedation, most of these models are derived from narrow patient populations, which restricts applicability for the overall population, including (small) children, elderly, and obese patients. This forces clinicians to select specific models for specific populations. Recent findings Recently, general purpose models have been developed for propofol and remifentanil using data from multiple studies and broad, diverse patient groups. General-purpose models might reduce the risks associated with extrapolation, incorrect usage, and unfamiliarity with a specific TCI-model, as they offer less restrictive boundaries (i.e., the patient “doesn’t fit in the selected model”) compared with the earlier, simpler models. Extrapolation of a model can lead to delayed recovery or inadequate anesthesia. If multiple models for the same drug are implemented in the pump, it is possible to select the wrong model for that specific case; this can be overcome with one general purpose model implemented in the pump. Summary This article examines the usability of these general-purpose models in relation to the more traditional models.
科研通智能强力驱动
Strongly Powered by AbleSci AI